256 related articles for article (PubMed ID: 27059798)
1. Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside.
Ferlin A; De Toni L; Sandri M; Foresta C
Br J Pharmacol; 2017 May; 174(10):1015-1024. PubMed ID: 27059798
[TBL] [Abstract][Full Text] [Related]
2. Relaxin-like peptides in male reproduction - a human perspective.
Ivell R; Agoulnik AI; Anand-Ivell R
Br J Pharmacol; 2017 May; 174(10):990-1001. PubMed ID: 27933606
[TBL] [Abstract][Full Text] [Related]
3. Relaxin family peptides: structure-activity relationship studies.
Patil NA; Rosengren KJ; Separovic F; Wade JD; Bathgate RAD; Hossain MA
Br J Pharmacol; 2017 May; 174(10):950-961. PubMed ID: 27922185
[TBL] [Abstract][Full Text] [Related]
4. INSL3: A Marker of Leydig Cell Function and Testis-Bone-Skeletal Muscle Network.
Facondo P; Delbarba A; Maffezzoni F; Cappelli C; Ferlin A
Protein Pept Lett; 2020; 27(12):1246-1252. PubMed ID: 32981493
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in the understanding of relaxin family peptides and their receptors.
Summers RJ
Br J Pharmacol; 2017 May; 174(10):915-920. PubMed ID: 28447360
[TBL] [Abstract][Full Text] [Related]
6. Relaxin and related peptides in male reproduction.
Agoulnik AI
Adv Exp Med Biol; 2007; 612():49-64. PubMed ID: 18161481
[TBL] [Abstract][Full Text] [Related]
7. Vascular actions of relaxin: nitric oxide and beyond.
Leo CH; Jelinic M; Ng HH; Marshall SA; Novak J; Tare M; Conrad KP; Parry LJ
Br J Pharmacol; 2017 May; 174(10):1002-1014. PubMed ID: 27590257
[TBL] [Abstract][Full Text] [Related]
8. INSL3 in the muscolo-skeletal system.
De Toni L; Agoulnik AI; Sandri M; Foresta C; Ferlin A
Mol Cell Endocrinol; 2019 May; 487():12-17. PubMed ID: 30625346
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the reproductive cycle and early pregnancy by relaxin family peptides.
Anand-Ivell R; Ivell R
Mol Cell Endocrinol; 2014 Jan; 382(1):472-479. PubMed ID: 23994019
[TBL] [Abstract][Full Text] [Related]
10. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.
Ma S; Smith CM; Blasiak A; Gundlach AL
Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604
[TBL] [Abstract][Full Text] [Related]
11. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
[TBL] [Abstract][Full Text] [Related]
12. The actions of relaxin on the human cardiovascular system.
Sarwar M; Du XJ; Dschietzig TB; Summers RJ
Br J Pharmacol; 2017 May; 174(10):933-949. PubMed ID: 27239943
[TBL] [Abstract][Full Text] [Related]
13. Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders.
Kumar JR; Rajkumar R; Jayakody T; Marwari S; Hong JM; Ma S; Gundlach AL; Lai MKP; Dawe GS
Br J Pharmacol; 2017 May; 174(10):1061-1076. PubMed ID: 27597467
[TBL] [Abstract][Full Text] [Related]
14. Genetic targeting of relaxin and insl3 signaling in mice.
Feng S; Bogatcheva NV; Kamat AA; Agoulnik AI
Ann N Y Acad Sci; 2005 May; 1041():82-90. PubMed ID: 15956690
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
[TBL] [Abstract][Full Text] [Related]
16. The role of insulin 3, testosterone, Müllerian inhibiting substance and relaxin in rat gubernacular growth.
Kubota Y; Temelcos C; Bathgate RA; Smith KJ; Scott D; Zhao C; Hutson JM
Mol Hum Reprod; 2002 Oct; 8(10):900-5. PubMed ID: 12356938
[TBL] [Abstract][Full Text] [Related]
17. Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.
Agoulnik AI; Agoulnik IU; Hu X; Marugan J
Br J Pharmacol; 2017 May; 174(10):977-989. PubMed ID: 27771940
[TBL] [Abstract][Full Text] [Related]
18. Anti-fibrotic actions of relaxin.
Samuel CS; Royce SG; Hewitson TD; Denton KM; Cooney TE; Bennett RG
Br J Pharmacol; 2017 May; 174(10):962-976. PubMed ID: 27250825
[TBL] [Abstract][Full Text] [Related]
19. Sex-specific effects of relaxin-3 on food intake and body weight gain.
Calvez J; de Ávila C; Timofeeva E
Br J Pharmacol; 2017 May; 174(10):1049-1060. PubMed ID: 27245781
[TBL] [Abstract][Full Text] [Related]
20. Expression of insulin-like factor 3 hormone-receptor system in the reproductive organs of male goats.
Pitia AM; Minagawa I; Uera N; Hamano K; Sugawara Y; Nagura Y; Hasegawa Y; Oyamada T; Sasada H; Kohsaka T
Cell Tissue Res; 2015 Nov; 362(2):407-20. PubMed ID: 26017634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
